Author:
Xiao Yangjiong,Jiang Yan,Song Hongmei,Liang Tao,Li Yonghui,Yan Dongliang,Fu Qiang,Li Zuowei
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Endzelins, E. et al. Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review. Molecular cancer 15, 41, doi: 10.1186/s12943-016-0523-5 (2016).
2. Nakazawa, M. & Kyprianou, N. Epithelial-Mesenchymal-Transition Regulators in Prostate Cancer: Androgens and Beyond. The Journal of steroid biochemistry and molecular biology, doi: 10.1016/j.jsbmb.2016.05.007 (2016).
3. Zuo, M., Xu, X., Li, T., Ge, R. & Li, Z. Progress in the mechanism and drug development of castration-resistant prostate cancer. Future medicinal chemistry 8, 765–788, doi: 10.4155/fmc.16.12 (2016).
4. Ferlay J., S. I., Ervik M., Dikshit R., Eser S., Mathers C., Rebelo M., Parkin D. M., Forman D., Bray & F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet], doi: Available at:
http://globocan.iarc.fr
(2013).
5. Duan, H. et al. SAG, a novel zinc RING finger protein that protects cells from apoptosis induced by redox agents. Molecular and cellular biology 19, 3145–3155 (1999).
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献